Found 8 results
Name | Type of Offering | Accepted Date |
---|---|---|
LexaGene Holdings Inc.
See All Filings
|
D | 2020-10-02 19:46:12 |
Amount To Be Raised
$1,659,999
Associated Brokers / Dealers
N/A
CIK Number
0001450416
Filed Document
0001183740-20-000212
Exclusions or Exemptions
506b
Accepted Date
2020-10-02 19:46:12
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
LexaGene Holdings Inc.
See All Filings
|
D/A | 2022-02-28 16:02:40 |
Amount To Be Raised
$11,470,000
Associated Brokers / Dealers
N/A
CIK Number
0001450416
Filed Document
0001183740-22-000044
Exclusions or Exemptions
506b
Accepted Date
2022-02-28 16:02:40
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
LexaGene Holdings Inc.
See All Filings
|
D | 2019-04-15 14:57:31 |
Amount To Be Raised
$265,840
Associated Brokers / Dealers
N/A
CIK Number
0001450416
Filed Document
0001183740-19-000063
Exclusions or Exemptions
506b
Accepted Date
2019-04-15 14:57:31
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
LexaGene Holdings Inc.
See All Filings
|
D | 2022-02-16 20:09:45 |
Amount To Be Raised
$8,131,750
Associated Brokers / Dealers
N/A
CIK Number
0001450416
Filed Document
0001183740-22-000040
Exclusions or Exemptions
506b
Accepted Date
2022-02-16 20:09:45
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
STONESHIELD CAPITAL CORP.
See All Filings
|
D | 2010-07-28 |
Amount To Be Raised
$21,375
Associated Brokers / Dealers
N/A
CIK Number
0001450416
Filed Document
0001085037-10-000261
Exclusions or Exemptions
N/A
Accepted Date
2010-07-28
Type of Offering
D
Industry
Other Energy
Offering Tier
N/A
Principal Place of Business
BRITISH COLUMBIA, CANADA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
LexaGene Holdings Inc.
See All Filings
|
D | 2019-11-07 14:26:27 |
Amount To Be Raised
$2,439,446
Associated Brokers / Dealers
N/A
CIK Number
0001450416
Filed Document
0001183740-19-000232
Exclusions or Exemptions
506b
Accepted Date
2019-11-07 14:26:27
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
LexaGene Holdings Inc.
See All Filings
|
D/A | 2022-02-16 16:31:20 |
Amount To Be Raised
$8,131,750
Associated Brokers / Dealers
N/A
CIK Number
0001450416
Filed Document
0001183740-22-000039
Exclusions or Exemptions
506b
Accepted Date
2022-02-16 16:31:20
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
LexaGene Holdings Inc.
See All Filings
|
D | 2022-11-16 13:36:37 |
Amount To Be Raised
$1,600,000
Associated Brokers / Dealers
N/A
CIK Number
0001450416
Filed Document
0001183740-22-000180
Exclusions or Exemptions
506b
Accepted Date
2022-11-16 13:36:37
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|